I agree that this site is using cookies. You can find further informations here.
X
Cui, Zhanglin Lin
246  results:
Search for persons X
?
1

Treatment patterns and outcomes associated with sequential ..:

Kruse, Megan ; Smyth, Emily Nash ; Bowman, Lee...
Breast Cancer Research and Treatment.  201 (2023)  1 - p. 105-115 , 2023
Link: https://doi.org/10.1007/..
 
?
2

Real-World Analysis of Clinical and Demographic Characteris..:

Ring, Alistair ; Karuturi, Meghan ; Smyth, Emily Nash...
Drugs - Real World Outcomes.  10 (2023)  4 - p. 589-603 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Characteristics and Outcomes in Cases of US Male Patients w..:

Ring, Alistair ; Karuturi, Meghan ; Smyth, Emily Nash...
Advances in Therapy.  40 (2023)  5 - p. 2515-2523 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Real-World Ramucirumab and Immune Checkpoint Inhibitor Sequ..:

Liepa, Astra M ; Cui, Zhanglin Lin ; Beyrer, Julie K..
Future Oncology.  19 (2023)  18 - p. 1277-1291 , 2023
Link: https://doi.org/10.2217/..
 
?
5

Generalizability of ORIENT-11 Trial Results to a US Standar..:

Nagasaka, Misako ; Molife, Cliff ; Cui, Zhanglin Lin...
Future Oncology.  18 (2022)  16 - p. 1963-1977 , 2022
Link: https://doi.org/10.2217/..
 
?
6

A Real-World US Study of Recurrence Risks using Combined Cl..:

Sheffield, Kristin M ; Peachey, Jessica R ; Method, Michael...
Future Oncology.  18 (2022)  21 - p. 2667-2682 , 2022
Link: https://doi.org/10.2217/..
 
?
7

Healthcare resource utilization in advanced non-small-cell ..:

Garon, Edward B. ; Winfree, Katherine B. ; Molife, Cliff...
Supportive Care in Cancer.  29 (2020)  1 - p. 117-125 , 2020
Link: https://doi.org/10.1007/..
 
?
8

Reliability of Conclusions from Early Analyses of Real-Worl..:

Hess, Lisa M ; Grabner, Michael ; Wang, Liya...
Pragmatic and Observational Research.  11 (2020)  - p. 27-43 , 2020
Link: https://doi.org/10.2147/..
 
?
9

Association of quality of life with disease characteristics..:

Chau, Ian ; Fuchs, Charles S. ; Ohtsu, Atsushi...
European Journal of Cancer.  107 (2019)  - p. 115-123 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Value of clinical trial narrative data to estimate the cost..:

Mladsi, Deirdre ; Hess, Lisa M. ; Barnett, Christine L....
Journal of Medical Economics.  23 (2019)  3 - p. 213-220 , 2019
Link: https://doi.org/10.1080/..
 
?
11

Sequential Therapy with Ramucirumab and/or Checkpoint Inhib..:

Molife, Cliff ; Hess, Lisa M ; Cui, Zhanglin Lin...
Future Oncology.  15 (2019)  25 - p. 2915-2931 , 2019
Link: https://doi.org/10.2217/..
 
?
12

Treatment patterns and survival outcomes for patients recei..:

Hess, Lisa M. ; Cui, Zhanglin Lin ; Mytelka, Daniel S....
International Journal of Colorectal Disease.  34 (2019)  4 - p. 581-588 , 2019
Link: https://doi.org/10.1007/..
 
?
13

Ramucirumab for the treatment of patients with gastric or g..:

Paulson, A. Scott ; Hess, Lisa M. ; Liepa, Astra M....
Gastric Cancer.  21 (2018)  5 - p. 831-844 , 2018
Link: https://doi.org/10.1007/..
 
?
14

Corrigendum to 'Ramucirumab as second-line treatment in pat..:

Chau, Ian ; Peck-Radosavljevic, Markus ; Borg, Christophe...
European Journal of Cancer.  100 (2018)  - p. 135-136 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Ramucirumab as second-line treatment in patients with advan..:

Chau, Ian ; Peck-Radosavljevic, Markus ; Borg, Christophe...
European Journal of Cancer.  81 (2017)  - p. 17-25 , 2017
Link: https://doi.org/10.1016/..
 
1-15